The Oncology Drug Discovery MSc course takes academic and biotech research knowledge and applies it to the development of 21st century health care.

There is an increasing need for graduates both locally and nationally, who can undertake lab based research, and translate it into improved knowledge and skill sets for research both inside and outside the academic community. This programme is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic.

With strong links forged between the local biotech industry and the Centre for Cancer Research and Cell Biology (CCRCB) the identification, validation and development of novel drug targets is gathering momentum. Within Queen’s University Belfast we have established links with Almac Discovery, CV6T and Fusion Antibodies. These links have significantly enhanced the capacity of the Drug Discovery Unit within the CCRCB to bring forward interesting new therapeutic targets and generate a training programme for students which provides an excellent insight into the drug discovery pathway.

Entry requirements

Applicants should normally possess a 2:1 Honours degree in a closely allied subject, or equivalent qualification acceptable to the University.

English language requirements

Evidence of an IELTS* score of 6.5, with not less than 6.0 in any component. *Taken within the last 2 years.

Tuition fees

£20,800 / ¥189,260